Integrating Clinical and Translational Research Networks-Building Team Medicine |
Autore | Salgia Ravi |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (250 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
renal cell carcinoma
team medicine translational research community practice clinical trials geriatric oncology older adults cancer clinical trials recruitment community team science bladder cancer urothelial carcinoma COVID-19 team-based medicine colorectal cancer precisian medicine academic and community oncology cancer center lung cancer lung cancer screening low-dose CT scans cancer prevention smoking cessation tobacco control national guidelines for screening and prevention pharmaceutical aids to smoking cessation non-small cell lung cancer driver mutations testing rates receptor tyrosine kinases actionable mutations next-generation sequencing fast-and-frugal trees personalized medicine minorities ethnicity race breast cancer research HER2-directed therapy community oncology academic cancer center precision medicine cancer genetics cancer genomics small cell lung cancer immunotherapy epithelial ovarian cancer frontline treatment surgical debulking adjuvant chemotherapy maintenance therapy PARP inhibitor genetics counseling clinical research oropharyngeal cancer concurrent chemoradiation therapy human papillomavirus feeding tube dependency value-based care value-based cancer care oncology pathways Early Recovery After Surgery (ERAS) team-based care oncology medical home integrated cancer care supportive care pathways surgical pathways cancer care plans |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557124403321 |
Salgia Ravi | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer |
Autore | Nakayama Naomi |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (258 p.) |
Soggetto topico | Public health & preventive medicine |
Soggetto non controllato |
nucleus accumbens-associated protein 1 (NAC1)
BEN (BANP, E5R and NAC1) domain sequence-specific DNA-binding protein solution NMR structure isothermal titration calorimetry (ITC) human cytomegalovirus ovarian cancer cancer progression inflammation immunosuppression endometrial carcinoma immune micro-environment immune checkpoints inhibitors microsatellite instability mismatch repair deficiency platelet-activating factor acetylhydrolase (PAF-AH PLA2G7) BRCA1 mutant ovarian cancer Wnt signaling pGSK3β β-catenin prognosis vulvar melanoma vaginal melanoma targeted therapy gynecological cancer melanoma treatment gene ontology epithelial ovarian cancers borderline ovarian tumors differentially expressed genes aryl hydrocarbon receptor epithelial-mesenchymal transition integrative analysis testin p16 protein cervical cancer cervical neoplasia immunohistochemistry chimeric antigen receptor CD44 adoptive immunotherapy NK cells epithelial ovarian cancer DNA damage response somatic mutation clear cell carcinoma endometrioid endometrial cancer DNA mismatch repair (MMR) MMR deficient (dMMR) long-term survival exosome miRNA biomarkers liquid biopsy interventional radiotherapy vaginal-cuff brachytherapy HDR brachytherapy in vivo dosimetry endometrial cancer biological planning drug repurposing non-coding RNAs nanocarriers anti-angiogenic therapy |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910580209103321 |
Nakayama Naomi | ||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|